⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303901 | 0.78 | — | — | |
| SCHEMBL6746850 | 0.65 | GABRA1 (0.31) | — | |
| SCHEMBL7455261 | 0.63 | — | — | |
| SCHEMBL9051617 | 0.60 | — | — | |
| SCHEMBL6550578 | 0.55 | — | — | |
| SCHEMBL7569561 | 0.49 | — | — | |
| SCHEMBL7409317 | 0.49 | — | — | |
| SCHEMBL11769613 | 0.48 | — | — | |
| SCHEMBL1887298 | 0.47 | — | — | |
| SCHEMBL4721785 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390722-B | Organic small molecular compound capable of distinguishing and detecting hydrazine and hypochlorite and preparation method thereof | 华南理工大学 | 2025-10-17 | — | — | CN | disclosed |
| CN-119390722-A | Organic small molecular compound capable of distinguishing and detecting hydrazine and hypochlorite and preparation method thereof | 华南理工大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-108884470-B | HPPD variants and methods of use | 巴斯夫农业种子解决方案美国有限责任公司 | 2023-07-25 | — | — | CN | disclosed |
| US-10913790-B2 | Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2021-02-09 | — | — | US | disclosed |
| US-20200206328-A1 | COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE | UNIV COLORADO REGENTS (US) | 2020-07-02 | — | — | US | disclosed |
| US-20200079836-A1 | COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTI TRYPSIN Fc FUSION MOLECULES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2020-03-12 | — | — | US | disclosed |
| US-20180133294-A1 | COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2018-05-17 | — | — | US | disclosed |
| US-9884096-B2 | Compositions and methods related to graft versus host disease and treatments thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170240615-A1 | COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN Fc FUSION MOLECULES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2017-08-24 | — | — | US | disclosed |
| EP-1909810-B2 | INHIBITORS OF SERINE PROTEASE ACTIVITY AND THEIR USE IN METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL | UNIV COLORADO REGENTS (US) | 2017-08-23 | — | — | EP | disclosed |
| WO-2005040194-A2 | METHODS AND COMPOSITIONS FOR PDGF-C ACTIVATION AND INHIBITION | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 2005-05-06 | — | — | WO | disclosed |
| US-6849605-B1 | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections | THE TRUSTEES OF UNIVERSITY TECHNOLOGY CORPORATION (US) | 2005-02-01 | — | — | US | disclosed |
| US-20040220239-A1 | Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions | BIO HOLDING, INC. | 2004-11-04 | — | — | US | disclosed |
| US-20040220242-A1 | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions | BIO HOLDING, INC. | 2004-11-04 | — | — | US | disclosed |
| US-20040220113-A1 | Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions | BIO HOLDING, INC. | 2004-11-04 | — | — | US | disclosed |
| US-6489308-B1 | ONE AGENT EXHIBITING MAMMALIAN ALPHA 1-ANTITRYPSIN OR ALPHA 1-ANTITRYPSIN-LIKE ACTIVITY, AND A FREE RADICAL SCAVENGER SUCH AS 2,6,8-TRIHYDROXYPURINE, DIHYDRORHODAMINE, OR A COMBINATION THEREOF | TRUSTEES OF UNIVERSITY OF TECHNOLOGY CORPORATION | 2002-12-03 | — | — | US | disclosed |
| US-6124291-A | TREATING AND PREVENTING THROMBOTIC DISORDERS | WARNER-LAMBERT COMPANY (US) | 2000-09-26 | — | — | US | disclosed |
| WO-2000052034-A2 | INHIBITORS OF SERINE PROTEASE ACTIVITY, METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONS | THE TRUSTEES OF UNIVERSITY TECHNOLOGY CORPORATION (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051623-A2 | INHIBITORS OF SERINE PROTEASE ACTIVITY, METHODS AND COMPOSITIONS FOR TREATMENT OF NITRIC OXIDE-INDUCED CLINICAL CONDITIONS | THE TRUSTEES OF UNIVERSITY TECHNOLOGY CORPORATION (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-1997048706-A1 | PYRROLO[1,2-A]PYRAZINE-1,4-DIONE SERINE PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1997-12-24 | — | — | WO | disclosed |